New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

Researchers at the Center for Innovation in Brain Science examined the impact of medication exposure in people with Type 2 diabetes on the risk of developing multiple sclerosis.

The study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.Continue reading

AZ FAST Grants – Apply by Dec 31 2022


The Arizona Commerce Authority has partnered with the Small Business Administration to facilitate the SBIR program in Arizona. Arizona’s FAST program provides funds, resources, training, and network opportunities to help entrepreneurs succeed in their SBIR proposal.

Please note: FAST Grant funding is only available to Arizona businesses seeking an SBIR-funded grant. FAST Grant applications are being accepted through December 31, 2022.






C-Path and Eisai Data Sharing Collaboration to Include Lennox-Gastaut Syndrome Registry and Clinical Trial Data

TUCSON, Ariz., Nov. 2, 2022 — Critical Path Institute (C-Path) and the Eisai Co., Ltd. (Eisai) today announced a joint collaboration to significantly promote data sharing and incorporate Lennox-Gastaut Syndrome (LGS) clinical trial data, into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading

CashLabs LLC Acquires Beacon Biomedical Inc.

Phoenix, Ariz. (November 1, 2022) – CashLabs LLC, a Tucson Arizona based national laboratory platform, announced the acquisition of Beacon Biomedical, a Phoenix Arizona based CLIA accredited medical laboratory focused on the development and commercialization of early detection cancer screening tests.Continue reading